問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
MacKay Memorial Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Others
下載
2018-12-01 - 2024-12-31
Condition/Disease
EARLY HER2-POSITIVE BREAST CANCER
Test Drug
Atezolizumab
Participate Sites5Sites
Terminated4Sites
Division of General Surgery
2018-10-01 - 2024-08-31
Participate Sites4Sites
2021-10-01 - 2027-12-31
Participate Sites8Sites
Recruiting8Sites
2017-09-01 - 2023-04-30
Participate Sites3Sites
Terminated3Sites
2012-11-30 - 2017-06-30
Participate Sites10Sites
Terminated10Sites
2010-07-01 - 2011-09-30
全部
